skip to main content

Chemistry, part 1

Content language

Contact us: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > ion > anion > polyatomic anion > oxoanion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > n-acetyl-beta-d-galactosaminyl-(1->4)-(alpha-n-acetyl-9-o-acetylneuraminosyl-(2->8)-alpha-n-acetylneuraminosyl-(2->3))-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1)-ceramide(2-) > n-acetyl-beta-d-galactosaminyl-(1->4)-(alpha-n-acetyl-9-o-acetylneuraminosyl-(2->8)-alpha-n-acetylneuraminosyl-(2->3))-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1)-ceramide(d18:1(4e))(2-)
... > chemical entity > molecular entity > ion > polyatomic ion > polyatomic anion > oxoanion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > n-acetyl-beta-d-galactosaminyl-(1->4)-(alpha-n-acetyl-9-o-acetylneuraminosyl-(2->8)-alpha-n-acetylneuraminosyl-(2->3))-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1)-ceramide(2-) > n-acetyl-beta-d-galactosaminyl-(1->4)-(alpha-n-acetyl-9-o-acetylneuraminosyl-(2->8)-alpha-n-acetylneuraminosyl-(2->3))-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1)-ceramide(d18:1(4e))(2-)
... > chemical entity > molecular entity > polyatomic entity > polyatomic ion > polyatomic anion > oxoanion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > n-acetyl-beta-d-galactosaminyl-(1->4)-(alpha-n-acetyl-9-o-acetylneuraminosyl-(2->8)-alpha-n-acetylneuraminosyl-(2->3))-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1)-ceramide(2-) > n-acetyl-beta-d-galactosaminyl-(1->4)-(alpha-n-acetyl-9-o-acetylneuraminosyl-(2->8)-alpha-n-acetylneuraminosyl-(2->3))-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1)-ceramide(d18:1(4e))(2-)
... > chemical entity > molecular entity > polyatomic entity > heteroatomic molecular entity > oxide > oxoanion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > n-acetyl-beta-d-galactosaminyl-(1->4)-(alpha-n-acetyl-9-o-acetylneuraminosyl-(2->8)-alpha-n-acetylneuraminosyl-(2->3))-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1)-ceramide(2-) > n-acetyl-beta-d-galactosaminyl-(1->4)-(alpha-n-acetyl-9-o-acetylneuraminosyl-(2->8)-alpha-n-acetylneuraminosyl-(2->3))-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1)-ceramide(d18:1(4e))(2-)
... > chemical entity > molecular entity > ion > anion > organic anion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > n-acetyl-beta-d-galactosaminyl-(1->4)-(alpha-n-acetyl-9-o-acetylneuraminosyl-(2->8)-alpha-n-acetylneuraminosyl-(2->3))-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1)-ceramide(2-) > n-acetyl-beta-d-galactosaminyl-(1->4)-(alpha-n-acetyl-9-o-acetylneuraminosyl-(2->8)-alpha-n-acetylneuraminosyl-(2->3))-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1)-ceramide(d18:1(4e))(2-)
... > chemical entity > molecular entity > ion > organic ion > organic anion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > n-acetyl-beta-d-galactosaminyl-(1->4)-(alpha-n-acetyl-9-o-acetylneuraminosyl-(2->8)-alpha-n-acetylneuraminosyl-(2->3))-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1)-ceramide(2-) > n-acetyl-beta-d-galactosaminyl-(1->4)-(alpha-n-acetyl-9-o-acetylneuraminosyl-(2->8)-alpha-n-acetylneuraminosyl-(2->3))-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1)-ceramide(d18:1(4e))(2-)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic ion > organic anion > carboxylic acid anion > carbohydrate acid derivative anion > anionic ganglioside > n-acetyl-beta-d-galactosaminyl-(1->4)-(alpha-n-acetyl-9-o-acetylneuraminosyl-(2->8)-alpha-n-acetylneuraminosyl-(2->3))-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1)-ceramide(2-) > n-acetyl-beta-d-galactosaminyl-(1->4)-(alpha-n-acetyl-9-o-acetylneuraminosyl-(2->8)-alpha-n-acetylneuraminosyl-(2->3))-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1)-ceramide(d18:1(4e))(2-)

Preferred term

n-acetyl-beta-d-galactosaminyl-(1->4)-(alpha-n-acetyl-9-o-acetylneuraminosyl-(2->8)-alpha-n-acetylneuraminosyl-(2->3))-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1)-ceramide(d18:1(4e))(2-)  

Type

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

Broader concept

charge

  • -2

formula

  • C63H103N4O35R

mass

  • 1476.500

monoisotopicmass

  • 1475.64029

smiles

  • [C@@]1(O[C@H]2[C@H]([C@H](O[C@H]([C@@H]2O)O[C@@H]3[C@H](O[C@@H](OC[C@@H]([C@@H](/C=C/CCCCCCCCCCCCC)O)NC(=O)*)[C@@H]([C@H]3O)O)CO)CO)O[C@H]4[C@@H]([C@H]([C@@H](O)[C@H](O4)CO)O)NC(C)=O)(O[C@]([C@H](NC(=O)C)[C@H](C1)O)([C@@H]([C@H](O[C@]5(O[C@]([C@@H]([C@H](C5)O)NC(C)=O)([C@@H]([C@@H](COC(=O)C)O)O)[H])C([O-])=O)CO)O)[H])C([O-])=O

subset

  • 2_STAR

synonym RELATED

  • a ganglioside Ac-O-9-GD2(d18:1(4E))
  • beta-D-GalNac-(1->4)-(alpha-N-Neu5,9Ac2-(2->8)-alpha-N-NeuAc-(2->3))-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1)-Cer(d18:1(4E))(2-)

In other languages

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:230468

Download this concept:

RDF/XML TURTLE JSON-LD